Primary hypertrophic osteoarthropathy: phenotypic variability and penetrance rate in heterozygotes for SLCO2A1 variantsJBMR PLUSIF2.42025-04-010OAAI
Could the Less-Than Subtotal Parathyroidectomy Be an Option for Treating Young Patients With Multiple Endocrine Neoplasia Type 1-Related Hyperparathyroidism?FRONTIERS IN ENDOCRINOLOGYIF4.62019-03-0717OAAI
Germline mutation landscape of multiple endocrine neoplasia type 1 using full gene next-generation sequencingEUROPEAN JOURNAL OF ENDOCRINOLOGYIF5.22018-12-0116OA
Assessment of Depression, Anxiety, Quality of Life, and Coping in Long-Standing Multiple Endocrine Neoplasia Type 2 PatientsTHYROIDIF6.72017-05-0121PREAI
RET Y791F Variant Does Not Increase the Risk for Medullary Thyroid CarcinomaTHYROIDIF6.72015-08-017PREAI
Penetrance and Clinical Features of Pheochromocytoma in a Six-Generation Family Carrying a Germline TMEM127 MutationJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISMIF5.12015-02-0138OAAI
Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibilityENDOCRINE-RELATED CANCERIF4.62014-11-2545OAAI
Association between the p27 rs2066827 variant and tumor multiplicity in patients harboring MEN1 germline mutationsEUROPEAN JOURNAL OF ENDOCRINOLOGYIF5.22014-09-0119OAAI
Assessment of the Removal Capacity, Tolerance, and Anatomical Adaptation of Different Plant Species to Benzene ContaminationWATER AIR AND SOIL POLLUTIONIF32014-07-0210PREAI
p27 variant and corticotropinoma susceptibility: a genetic and in vitro studyENDOCRINE-RELATED CANCERIF4.62014-02-1413OAAI
Penetrance of Functioning and Nonfunctioning Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1 in the Second Decade of LifeJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISMIF5.12014-01-0153OA
In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomasENDOCRINE-RELATED CANCERIF4.62013-03-26118OAAI
Exomic Sequencing of Medullary Thyroid Cancer Reveals Dominant and Mutually Exclusive Oncogenic Mutations in RET and RASJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISMIF5.12013-02-01198OA
Assessing the emerging oncogene protein kinase C epsilon as a candidate gene in families with Carney complex-2CLINICAL ENDOCRINOLOGYIF2.42011-12-072PREAI
Somatotroph pituitary adenoma with acromegaly and autosomal dominant polycystic kidney disease: SSTR5 polymorphism and PKD1 mutationPITUITARYIF3.42011-07-0910OA
Spectrum and Prevalence of FP/TMEM127 Gene Mutations in Pheochromocytomas and ParagangliomasJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONIF552010-12-15157OA
Risk Profiles and Penetrance Estimations in Multiple Endocrine Neoplasia Type 2A Caused by Germline RET Mutations Located in Exon 10HUMAN MUTATIONIF3.72010-11-16106OAAI
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative StudyJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISMIF5.12010-11-01289OAAI
Early-Onset, Progressive, Frequent, Extensive, and Severe Bone Mineral and Renal Complications in Multiple Endocrine Neoplasia Type 1-Associated Primary HyperparathyroidismJOURNAL OF BONE AND MINERAL RESEARCHIF5.92010-04-3067OAAI
Bone mineral density analysis in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 after total parathyroidectomyCLINICAL ENDOCRINOLOGYIF2.42010-03-0331PREAI